Abstract:Deep sternal wound infection is a severe complication after open heart surgery. According to the different severity and dimensions of the deep sternal wound infection, the treatment method is different. In this study, we aimed to describe our experience with the rectus abdominis myocutaneous flap for large sternal wound management, especially when 1 or 2 internal mammary arteries were absent.Between October 2010 and January 2016, a retrospective review of 9 patients who suffered from the extensive thoracic def… Show more
“… 50 Anastomosing the IEA to the intercostal artery or IMA perforator to create an RA flap with a dual blood supply in cases where either a single or both IMAs have been used for the bypass graft has also been described, with no reported complications of distal flap necrosis, and all flaps healing without recurrence of infection. 51 This study is limited however by the very small sample size, and therefore it is not possible to draw any strong conclusions from this data.…”
Deep sternal wound infection (DSWI) is an important complication of open thoracic surgery, with a reported incidence of 0.5–6%. Given its association with increased morbidity, mortality, inpatient duration, financial burden, and re-operation rates, an aggressive approach to treatment is mandated. Flap reconstruction has become the standard of care, with studies demonstrating improved outcomes with reduced mortality and resource usage in patients undergoing early versus delayed flap reconstruction. Despite this, no evidence-based standard for the management of DSWI exists.
We performed a thorough review of the literature to identify principles in management, using a PRISMA compliant methodology. Ovid-Embase, Medline and PubMed databases were searched for relevant papers using the search terms “deep sternal wound infection,” and “post-sternotomy mediastinitis” to December 2019. Duplicates were removed, and the search narrowed to look at specific areas of interest i.e. negative pressure wound therapy, flap reconstruction, and rigid fixation. The reference list of included articles underwent full text review. No randomized controlled trials were identified.
We review the current management techniques for patients with DSWI, and raise awareness for the need for further high quality studies, and a standardized national cardiothoracic-plastic surgery guideline to guide management. Based on our findings and the authors’ own experience in this area, we provide evidence-based recommendations. We also propose a reconstructive algorithm.
“… 50 Anastomosing the IEA to the intercostal artery or IMA perforator to create an RA flap with a dual blood supply in cases where either a single or both IMAs have been used for the bypass graft has also been described, with no reported complications of distal flap necrosis, and all flaps healing without recurrence of infection. 51 This study is limited however by the very small sample size, and therefore it is not possible to draw any strong conclusions from this data.…”
Deep sternal wound infection (DSWI) is an important complication of open thoracic surgery, with a reported incidence of 0.5–6%. Given its association with increased morbidity, mortality, inpatient duration, financial burden, and re-operation rates, an aggressive approach to treatment is mandated. Flap reconstruction has become the standard of care, with studies demonstrating improved outcomes with reduced mortality and resource usage in patients undergoing early versus delayed flap reconstruction. Despite this, no evidence-based standard for the management of DSWI exists.
We performed a thorough review of the literature to identify principles in management, using a PRISMA compliant methodology. Ovid-Embase, Medline and PubMed databases were searched for relevant papers using the search terms “deep sternal wound infection,” and “post-sternotomy mediastinitis” to December 2019. Duplicates were removed, and the search narrowed to look at specific areas of interest i.e. negative pressure wound therapy, flap reconstruction, and rigid fixation. The reference list of included articles underwent full text review. No randomized controlled trials were identified.
We review the current management techniques for patients with DSWI, and raise awareness for the need for further high quality studies, and a standardized national cardiothoracic-plastic surgery guideline to guide management. Based on our findings and the authors’ own experience in this area, we provide evidence-based recommendations. We also propose a reconstructive algorithm.
“…Hereby, the most prevalent reconstructive options usually comprise pedicled muscle flaps, as they provide well-vascularized tissue with enough bulk to fill the defect cavity. The pedicled VRAM flap, LD flap, and bilateral pectoralis major flap have been the method of choice for decades [ 5 , 6 , 8 ]. In this context, it is recommended to cover cranial sternal wounds with pectoralis major flaps, whereas VRAM flaps are of better use to cover caudal sternal wounds.…”
Section: Discussionmentioning
confidence: 99%
“…When both internal mammary arteries (IMAs) have been harvested for coronary-artery bypass grafts (CABG) or after previous local flap failure, reconstruction can be difficult. This is partially due to the fact that the arc of rotation of pedicled flaps is limited [ 5 , 6 ] and closure of defects, which include the entirety of the sternum, can be critical, putting the most distal part of the pedicled flap at risk of impaired perfusion [ 7 , 8 ]. To offer these multimorbid patients the best possible care and optimal long-term outcomes, we are increasingly using the free myocutaneous tensor fasciae latae (TFL) flap for extended deep sternal defect reconstruction.…”
Introduction: Deep sternal wound infections (DSWI) after cardiac surgery pose a significant challenge in reconstructive surgery. In this context, free flaps represent well-established options. The objective of this study was to investigate the clinical outcome after free myocutaneous tensor fasciae latae (TFL) flap reconstruction of sternal defects, with a special focus on surgical complications and donor-site morbidity. Methods: A retrospective chart review focused on patient demographics, operative details, and postoperative complications. Follow-up reexaminations included assessments of the range of motion and muscle strength at the donor-site. Patients completed the Quality of Life 36-item Short Form Health Survey (SF-36) as well as the Lower Extremity Functional Scale (LEFS) questionnaire and evaluated aesthetic and functional outcomes on a 6-point Likert scale. The Vancouver Scar Scale (VSS) and the Patient and Observer Scar Assessment Scales (POSAS) were used to rate scar appearance. Results: A total of 46 patients (mean age: 67 ± 11 years) underwent sternal defect reconstruction with free TFL flaps between January 2010 and March 2021. The mean defect size was 194 ± 43 cm2. The mean operation time was 387 ± 120 min with a flap ischemia time of 63 ± 16 min. Acute microvascular complications due to flap pedicle thromboses occurred in three patients (7%). All flaps could be salvaged without complete flap loss. Partial flap loss of the distal TFL portion was observed in three patients (7%). All three patients required additional reconstruction with pedicled or local flaps. Upon follow-up, the range of motion (hip joint extension/flexion (p = 0.73), abduction/adduction (p = 0.29), and internal/external rotation (p = 0.07)) and muscle strength at the donor-sites did not differ from the contralateral sides (p = 0.25). Patient assessments of aesthetic and functional outcomes, as well as the median SF-36 (physical component summary (44, range of 33 to 57)) and LEFS (54, range if 35 to 65), showed good results with respect to patient comorbidities. The median VSS (3, range of 2 to 7) and POSAS (24, range of 18 to 34) showed satisfactory scar quality and scar appearance. Conclusion: The free TFL flap is a reliable, effective, and, therefore, valuable option for the reconstruction of extensive sternal defects in critically ill patients suffering from DSWIs. In addition, the TFL flap shows satisfactory functional and aesthetic results at the donor-site.
“…After serial surgical debridements, the lower third anterior chest wall defect was confirmed to be clean with skeletal stability. Therefore, we decided to cover the defect using a VRAM flap because it is a well-vascularized soft tissue flap suitable for controlling infection and obliterating dead space [11,13]. It is also a versatile and robust muscle flap that yields a considerable volume of local tissue with similar texture and appearance to the chest region [11].…”
Although blast injuries have been considered a problem unique to military practice or warfare, accidental civilian blast-related injuries due to misplaced landmines have been reported in South Korea. A 71-year-old man was admitted to the emergency room due to multiple severe blast injuries after the detonation of an unknown explosive device. After shrapnel that penetrated the pericardium was removed via median sternotomy in an emergency operation, an extensive defect remained on the lower third of the anterior chest wall. After debriding the contaminated wound several times, chest wall reconstruction with a skin-paddled vertical rectus abdominis muscle (VRAM) flap was successfully performed. However, the patient presented a delayed fungal infection of the deep sternal wound 28 days postoperatively. To salvage the previous flap, antifungal agents were administered and negative-pressure wound therapy was performed between serial radical debridement. The previous flap was successfully salvaged with infection control, and the final defect was covered by re-rotating the previous flap. This case presents the successful reconstruction of a chest wall defect using a skin-paddled VRAM flap notwithstanding a delayed sternal wound infection from a rare civilian blast injury in South Korea.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.